Literature DB >> 24752934

Predicting who benefits most from cognitive-behavioral therapy for anxiety and depression.

Jesse Renaud1, Jennifer J Russell, Gail Myhr.   

Abstract

OBJECTIVES: We examined core features of patient suitability for cognitive-behavioral therapy (CBT) and their ability to predict CBT outcomes.
METHOD: A sample of 256 outpatients diagnosed with depression and anxiety disorders were assessed using the Suitability for Short-Term Cognitive Therapy (SSCT) scale. Therapists rated patients' symptom severity using the Clinical Global Impression scale before and after therapy.
RESULTS: A factor analysis of the SSCT scale yielded 2 factors: (a) Capacity for Participation in CBT Process and (b) Attitudes Relevant to the CBT Process. A multiple regression analysis revealed that only Capacity for Participation in CBT Process uniquely predicted improvement at termination.
CONCLUSIONS: These findings highlight the importance of assessing the suitability of CBT for individual patients. Specifically, patients with greater capacity to identify and articulate thoughts and feelings and to share them in a nondefensive, focused way benefit most from CBT.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  anxiety; cognitive-behavioral therapy; depression; factor analysis; suitability

Mesh:

Year:  2014        PMID: 24752934     DOI: 10.1002/jclp.22099

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  5 in total

Review 1.  Family Accommodation of Child and Adolescent Anxiety: Mechanisms, Assessment, and Treatment.

Authors:  Kaila R Norman; Wendy K Silverman; Eli R Lebowitz
Journal:  J Child Adolesc Psychiatr Nurs       Date:  2015-08-04

2.  Effectiveness of cognitive behavioral group therapy for depression in routine practice.

Authors:  Jens C Thimm; Liss Antonsen
Journal:  BMC Psychiatry       Date:  2014-10-21       Impact factor: 3.630

3.  A Logic-Based Psychotherapy Approach to Treating Patients Which Focuses on Faultless Logical Functioning: A Case Study Method.

Authors:  Fernando Almeida; Diana Moreira
Journal:  Front Psychol       Date:  2017-12-22

4.  A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disorders.

Authors:  Christopher Rayner; Jonathan R I Coleman; Kirstin L Purves; John Hodsoll; Kimberley Goldsmith; Georg W Alpers; Evelyn Andersson; Volker Arolt; Julia Boberg; Susan Bögels; Cathy Creswell; Peter Cooper; Charles Curtis; Jürgen Deckert; Katharina Domschke; Samir El Alaoui; Lydia Fehm; Thomas Fydrich; Alexander L Gerlach; Anja Grocholewski; Kurt Hahlweg; Alfons Hamm; Erik Hedman; Einar R Heiervang; Jennifer L Hudson; Peter Jöhren; Robert Keers; Tilo Kircher; Thomas Lang; Catharina Lavebratt; Sang-Hyuck Lee; Kathryn J Lester; Nils Lindefors; Jürgen Margraf; Maaike Nauta; Christiane A Pané-Farré; Paul Pauli; Ronald M Rapee; Andreas Reif; Winfried Rief; Susanna Roberts; Martin Schalling; Silvia Schneider; Wendy K Silverman; Andreas Ströhle; Tobias Teismann; Mikael Thastum; Andre Wannemüller; Heike Weber; Hans-Ulrich Wittchen; Christiane Wolf; Christian Rück; Gerome Breen; Thalia C Eley
Journal:  Transl Psychiatry       Date:  2019-05-23       Impact factor: 6.222

5.  Patient characteristics and changes in anxiety symptoms in patients with panic disorder: Post-hoc analysis of the PARADIES cluster randomised trial.

Authors:  Tobias Dreischulte; Karoline Lukaschek; Marietta Rottenkolber; Jana Werle; Thomas S Hiller; Jörg Breitbart; Ulrike Schumacher; Christian Brettschneider; Jürgen Margraf; Jochen Gensichen
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.